A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity

Clinical trial NCT06830863 · RECRUITING

Trial details

NCT number: NCT06830863
Sponsor: Azitra Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

EGFR Inhibitor-associated Rash

Start date: 2025-08-25
Primary completion: 2027-01-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.